Overall market sentiment has been high on ProPhase Labs Inc (PRPH) stock lately. PRPH receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.
ProPhase Labs Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PRPH!
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With PRPH Stock Today?
ProPhase Labs Inc (PRPH) stock is trading at $12.15 as of 3:43 PM on Monday, Aug 15, a gain of $0.66, or 5.74% from the previous closing price of $11.49. The stock has traded between $11.50 and $12.46 so far today. Volume today is 258,101 compared to average volume of 243,094.
To screen for more stocks like ProPhase Labs Inc click here.
More About ProPhase Labs Inc
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
Click Here to get the full Stock Report for ProPhase Labs Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
